CFO
PODD icon

Callan Family Office’s Insulet PODD Stock Holding History

Callan Family Office’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Buy
1,490
+28
+2% +$7.04K 0.01% 916
2025
Q4 		$416K Buy
1,462
+374
+34% +$117K 0.01% 831
2025
Q3 		$336K Sell
1,088
-105
-9% -$32.9K 0.01% 661
2025
Q2 		$375K Buy
+1,193
New +$344K 0.01% 695

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Callan Family Office's PODD Position: Q1 2026 in Review

Callan Family Office increased its Insulet (PODD) stake by 1.9% in Q1 2026, buying an estimated $7.04K and bringing the position to 1,490 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #916.

Callan Family Office first reported a position in PODD in Q2 2025 and has held it in 4 quarters since. The position peaked at $416K in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Callan Family Office held 1,490 shares of Insulet worth $313K as of Q1 2026.
  • Callan Family Office bought 28 Insulet shares in Q1 2026, an estimated $7.04K.
  • Insulet made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #916 holding.
  • Callan Family Office first reported a position in Insulet in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Insulet position peaked at $416K in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.